Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Opioid abuse

  • U.S. Senator Launches Probe into Five Top Opioid Drugmakers

    U.S. Democratic Senator Claire McCaskill has sought details from the nation’s top opioid drugmakers on their sales...
  • U.S. DEA Temporarily Bans Synthetic Opioid “Pink” after 46 Deaths

    (Reuters) – The U.S. Drug Enforcement Administration (DEA) said on Thursday it had temporarily categorized a synthetic...
  • Cigna Ends Preauthorization Requirement to Treat Opioid Addiction

    (Reuters) – Health insurer Cigna Corp. has discontinued its policy of requiring doctors to seek authorization before...

U.S. Senator Launches Probe into Five Top Opioid Drugmakers

April 18, 2017 - Reuters Staff (Reuters) - 1 Comment

U.S. Democratic Senator Claire McCaskill has sought details from the nation’s top opioid drugmakers on their sales…

Read More

U.S. DEA Temporarily Bans Synthetic Opioid “Pink” after 46 Deaths

December 13, 2016 - Natalie Grover - 0 Comment

(Reuters) – The U.S. Drug Enforcement Administration (DEA) said on Thursday it had temporarily categorized a synthetic…

Read More

Cigna Ends Preauthorization Requirement to Treat Opioid Addiction

November 7, 2016 - Natalie Grover - 0 Comment

(Reuters) – Health insurer Cigna Corp. has discontinued its policy of requiring doctors to seek authorization before…

Read More

Virginia College Publicizes New Opioid Prescribing Guidelines Beyond Medical Community, Opens Wider Discussion About Addiction

September 20, 2016 - Brian Dawson, MD, MBA, CPE, FACEP - 1 Comment

According to a 2015 American Journal of Preventive Medicine study, the largest percentage drop in opioid prescribing…

Read More

U.S. Republicans Reject Democratic Funding Proposals for Opioids

July 20, 2016 - Reuters Staff - 0 Comment

Republican lawmakers in U.S. Congress have rejected two Democratic amendments to provide nearly $1 billion in funding…

Read More

Current Issue

ACEP Now: November 2025

Download PDF

Read More

Polls

Which topic would you like to see ACEP Now tackle?

View Results

Loading ... Loading ...
  • Polls Archive
Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603